Connect with us
A new study in The Lancet shows annual lenacapavir injections could revolutionize HIV prevention, with up to 100% risk reduction in trials. While effective, challenges include...
AstraZeneca is acquiring Belgian biotech EsoBiotec for up to $1 billion to enhance its cancer therapy portfolio. EsoBiotec's innovative ENaBL platform enables rapid, cost-effective cell therapy...
Giftify, Inc. [NASDAQ: GIFT] saw a record 916% increase in category sales revenue following the launch of its GLP-1 savings campaign. Now, the company is building...
EmTech Italy 2025, organized by MIT Technology Review Italia and Campus Bio-Medico University of Rome, debuted in Italy, focusing on AI’s impact on healthcare, energy, and...
Enea Tech and Biomedical, a publicly funded foundation supporting biotech innovation, has overcome past doubts with major investments. In 2024, it approved €80M for 16 startups,...
Andalusia has advanced breast cancer prevention with a 426% rise in investment, reaching €157.4 million (2019–2023). In 2024, 789,065 women were invited to screening, with 71.55%...
Quinton BioTech Labs closed 2024 with 3.3% growth, reaching €8.5M in revenue. Spain grew 13%, driven by Quinton Medical, while the Czech Republic and Romania saw...
The INCLIVA Health Research Institute hosted TERRETA, a forum uniting researchers, clinicians, and patients to advance treatments for rare genetic diseases caused by repeat expansions. The...
Catalan startup PLANeT Biotech develops bioactive molecules that help crops withstand climate change-induced stress like drought and heat. Supported by a €100,000 government grant, the company’s...
Giftify [NASDAQ: GIFT] is disrupting the GLP-1 market with a smart savings model providing consumers with discounted Ozempic and Wegovy. With the FDA closing the loophole...
 |
|
 |  |
 |
|